{
    "clinical_study": {
        "@rank": "77187", 
        "arm_group": [
            {
                "arm_group_label": "Endobiliary RFA group", 
                "arm_group_type": "Experimental", 
                "description": "Endoscopic retrograde cholangiopancreatography (ERCP) would be performed under standard operating conditions to confirm the biliary malignancy. Subjects will receive endobiliary radiofrequency ablation (Endobiliary RFA) followed by plastic stent(s) placement.\nThree months later, subjects will receive the second RFA therapy followed by biliary stents (plastic or SEMS) placement.\nDuring follow-up, if stent occlusion occurs, the patient will undergo endoscopic re-intervention for stent exchange without endobiliary RFA"
            }, 
            {
                "arm_group_label": "Control group", 
                "arm_group_type": "No Intervention", 
                "description": "Endoscopic retrograde cholangiopancreatography (ERCP) would be performed under standard operating conditions to confirm the biliary malignancy. Subjects will receive plastic biliary stent(s) placement only.\nThree months later, subjects will receive the second endoscopic intervention for stents (plastic or SEMS) exchange.\nDuring follow-up, if stent occlusion occurs, the patient will undergo endoscopic re-intervention for stent exchange without endobiliary RFA"
            }
        ], 
        "brief_summary": {
            "textblock": "Only a small proportion of patients with cholangiocarcinoma or ampullary carcinoma are\n      suitable for surgical resection. The endoscopic or percutaneous transhepatic biliary\n      drainage is accepted approaches for the relief of jaundice in malignant biliary obstruction.\n      But restoration of bile flow have few improvement of the survival of cancer patient. By\n      using endobiliary radiofrequency energy to destruct the tumorous tissue may delay tumour\n      growth, which might improve the survival of patients. The feasibility and safety of this\n      technique using HabibTM EndoHBP probe has been evident. The aims of this randomised,\n      controlled, multicentre study is to evaluate whether endobiliary radiofrequency\n      ablation(RFA) can improve the median survival of patients with unresectable biliary\n      malignancy."
        }, 
        "brief_title": "Endobiliary RFA for Unresectable Malignant Biliary Strictures", 
        "completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Cholangiocarcinoma", 
            "Ampullary Carcinoma"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma", 
                "Cholangiocarcinoma", 
                "Cholestasis", 
                "Constriction, Pathologic"
            ]
        }, 
        "detailed_description": {
            "textblock": "RFA is well established method for treatment of some solid tumors, like  liver cancer, lung\n      cancer, etc. Recently, an endoscopically applicable radiofrequency probe, HabibTM EndoHBP\n      catheter, was approved for clinical use. It uses bipolar electrical energy for tissue\n      coagulation and can be easily applied during endoscopic retrograde cholangiopancreatography\n      (ERCP). Endobiliary radiofrequency can destruct the tumor tissue and has potential benefit\n      for controlling tumour growth. Several cohort studies have been published and the\n      feasibility and safety of such technique has been proved.\n\n      The aims of this study is to conduct a randomised, controlled, multicentre clinical trial to\n      compare the effect of endobiliary RFA plus biliary stenting with only biliary stenting in\n      patients with unresectable cholangiocarcinoma or ampullary carcinoma.\n\n      The objectives are\n\n        -  To evaluate whether endobiliary RFA prior to biliary stenting can improve the patients'\n           survival as compared to the only stenting therapy.\n\n        -  To assess the impact of RFA on the stent's patency."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Either gender greater than or equal to 18 years of age.\n\n          -  Cholangiocarcinoma or ampullary cancer unsuitable for surgical resection by staging,\n             comorbidities or patient wishes. Criteria of unresectability being based on 1)\n             metastatic disease or 2) locally advanced.\n\n          -  Biliary obstruction, Bilirubin > 40umol/L at diagnosis\n\n          -  Subjects capable of giving informed consent\n\n          -  Life expectancy of at least 3 months\n\n          -  Histologically (preferred) or radiologically confirmed cholangiocarcinoma or\n             ampullary cancer\n\n        Exclusion Criteria:\n\n          -  Cardiac Pacemaker\n\n          -  Patient unstable for endoscopy\n\n          -  Inability to give informed consent\n\n          -  Coagulopathy (INR > 2.0 or PTT > 100 sec or platelet count < 50,000)\n\n          -  Performance status ECOG \u22653 (confined to bed / chair > 50% waking hours)\n\n          -  Active suppurative cholangitis\n\n          -  Complex stenoses will not be eligible for the trial\n\n          -  Patients without access to duodenum or ampulla are not candidates for ERCP and\n             stenting\n\n          -  Malignant ascites\n\n          -  Presence of main portal vein thrombosis\n\n          -  Prior stents placement\n\n          -  Prior Billroth II or roux-en Y reconstruction\n\n          -  Inability to insert a guide wire across the malignant stricture\n\n          -  Pregnancy\n\n          -  Presence of other malignancy\n\n          -  Life expectancy < 3months"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "240", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 28, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01844245", 
            "org_study_id": "EHBH B-RFA 2013-001"
        }, 
        "intervention": {
            "arm_group_label": "Endobiliary RFA group", 
            "description": "The RFA probe is introduced into bile duct. Bipolar electronic coagulation is performed to the tumorous segment.", 
            "intervention_name": "Radiofrequency ablation (RFA)", 
            "intervention_type": "Procedure", 
            "other_name": "Endobiliary RFA"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Cholangiocarcinoma", 
            "Ampullary carcinoma", 
            "Endoscopic retrograde cholangiopancreatography", 
            "Radiofrequency ablation"
        ], 
        "lastchanged_date": "April 21, 2014", 
        "location": [
            {
                "contact": {
                    "last_name": "Ming Ji, Doctor", 
                    "phone": "+86-10-63138339"
                }, 
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China", 
                        "state": "Beijing", 
                        "zip": "100050"
                    }, 
                    "name": "Beijing Friendship Hospital Affiliated to Capital University of Medical Sciences"
                }, 
                "investigator": {
                    "last_name": "Ming Ji, Doctor", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "jihaxi@163.com", 
                    "last_name": "Hai-xing Jiang, M.D.", 
                    "phone": "+86-771-5356725"
                }, 
                "facility": {
                    "address": {
                        "city": "Nanning", 
                        "country": "China", 
                        "state": "Guangxi", 
                        "zip": "530021"
                    }, 
                    "name": "The First Affiliated Hospital of Guangxi Medical University"
                }, 
                "investigator": {
                    "last_name": "Hai-xing Jiang, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "shuren_ma@163.com", 
                    "last_name": "Shu-Ren Ma, Doctor", 
                    "phone": "+86-24-28886666"
                }, 
                "facility": {
                    "address": {
                        "city": "Shenyang", 
                        "country": "China", 
                        "state": "Liaoning", 
                        "zip": "110015"
                    }, 
                    "name": "The General Hospital of Shenyang Military Region"
                }, 
                "investigator": {
                    "last_name": "Shu-Ren Ma, Doctor", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "drhubing@yahoo.cn", 
                    "last_name": "Bing Hu, Doctor", 
                    "phone": "+86-21-81875221"
                }, 
                "contact_backup": {
                    "email": "gaodj1975@126.com", 
                    "last_name": "Dao-Jian Gao, Doctor", 
                    "phone": "+86-21-81875222"
                }, 
                "facility": {
                    "address": {
                        "city": "Shanghai", 
                        "country": "China", 
                        "state": "Shanghai", 
                        "zip": "200438"
                    }, 
                    "name": "Eastern Hepatobiliary Surgery Hospital"
                }, 
                "investigator": [
                    {
                        "last_name": "Bing Hu, Doctor", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Dao-Jian Gao, Doctor", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "gxuegang@fmmu.edu.cn", 
                    "last_name": "Xue-Gang Guo, Doctor"
                }, 
                "facility": {
                    "address": {
                        "city": "Xi'an", 
                        "country": "China", 
                        "state": "Shanxi", 
                        "zip": "710032"
                    }, 
                    "name": "Xijing Hospital of the Forth Military Medical University"
                }, 
                "investigator": {
                    "last_name": "Xue-Gang Guo, Doctor", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "zxf837@tom.com", 
                    "last_name": "Xiao-Feng Zhang, Doctor", 
                    "phone": "+86-571-87065701"
                }, 
                "facility": {
                    "address": {
                        "city": "Hangzhou", 
                        "country": "China", 
                        "state": "Zhejiang", 
                        "zip": "310006"
                    }, 
                    "name": "Hangzhou First People's Hospital"
                }, 
                "investigator": {
                    "last_name": "Xiao-Feng Zhang, Doctor", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "Endoscopic Radiofrequency Ablation for Malignant Biliary Strictures Due to Unresectable Cholangiocarcinoma or Ampullary Carcinoma: a Randomised, Controlled, Multicentre Clinical Trial", 
        "overall_contact": {
            "email": "drhubing@yahoo.cn", 
            "last_name": "Bing Hu, MD, PhD", 
            "phone": "+86-21-81875221"
        }, 
        "overall_contact_backup": {
            "email": "gaodj1975@126.com", 
            "last_name": "Dao-Jian Gao, MD, PhD", 
            "phone": "+86-21-81875222"
        }, 
        "overall_official": {
            "affiliation": "Eastern Hepatobiliary Surgery Hospital, The Second Military Medical University", 
            "last_name": "Bing Hu, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Science and Technology Commission of Shanghai Municipality", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Overall survival", 
            "safety_issue": "Yes", 
            "time_frame": "2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01844245"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Eastern Hepatobiliary Surgery Hospital", 
            "investigator_full_name": "Bing Hu", 
            "investigator_title": "Professor, Head of Endoscopy Center", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Patency of stents", 
                "safety_issue": "Yes", 
                "time_frame": "6 months"
            }, 
            {
                "measure": "Unscheduled readmission rates", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "measure": "Serious adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "30 days"
            }
        ], 
        "source": "Eastern Hepatobiliary Surgery Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Bing Hu", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}